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	 
 
Effective dissemination of technology in global surgery is vital if we are to realise 
Universal Health Coverage by 2030. Challenges include a lack of human resource, 
infrastructure and finances. Understanding these challenges, and exploring 
opportunities and solutions to overcome them, will be essential to improve global 
surgical care. 
 
 
 
This review focuses on technologies and medical devices aimed at improving 
surgical care and training in low and middleBincome countries. We describe the key 
considerations in the development of new technologies along with strategies for 
evaluation and wider dissemination, and illustrate this with notable examples of 
where the dissemination of a new surgical technology has achieved impact.  
 
 
 
Employing the principles of frugal and responsible innovation, and aligning 
evaluation and development to high scientific standards helps overcome some of the 
challenges in disseminating technology in global surgery. Exemplars of effective 
dissemination include lowBcost laparoscopes, gasless laparoscopic techniques and 
innovative training programmes for laparoscopic surgery; lowBcost and versatile 
external fixation devices for fractures; the LifeBox pulse oximeter project; and the 
use of immersive technologies in simulation, training and surgical care delivery.   
 
 
 
Principal core strategies to facilitate technology dissemination in global surgery 
include leveraging international funding, interdisciplinary collaboration involving all 
key stakeholders, and frugal scientific design, development and evaluation. Process 
and system innovations and evaluations considering the wider context are also 
required to implement and disseminate surgical technology effectively. Practical and 
contextBspecific guidance for actors in global surgical technologies will improve 
technology dissemination and outcomes for patients in LMICs. 
 
 

















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Technology is playing an increasing role in the delivery of healthcare with particular 
impact on the delivery of surgical and perioperative care 1–3. Healthcare in low and 
middleBincome countries (LMICs) suffers from a lack of technological development 
and adoption, which needs to be addressed if the World Health Organisations 
(WHO) ambition of Universal Health Coverage (UHC) is to be realised by 20304–6. 
This presents many challenges above those frequently encountered in highBincome 
countries (HICs). Understanding these challenges, and exploring opportunities and 
solutions to overcome them, will be essential to improve global surgical care. 
 
Technology dissemination is a complex process involving need assessment, 
conception, innovative research, development and evaluation, and wider 
implementation and adoption7. Challenges include a lack of human resource, 
infrastructure and finances. Additionally, countryBspecific healthcare system factors, 
regulatory factors and local environmental factors all make technology dissemination 
more difficult. Understanding the specific clinical and healthcare system needs and 
generating an evidence base to address these, which includes costBeffectiveness 
within the lowBresource settings, is essential to inform wider dissemination and 
adoption. In addition, the appropriate system and process infrastructure is required 
to ensure effective implementation. 
 
The Lancet Commission on Global Surgery recognised that novel technologies are 
key enabling factors in the realisation of its goal to scale up and strengthen surgical 
care worldwide by 20308. Specifically, it identified the need to reduce costs, optimise 
healthcare system and resource use, and improve the delivery of surgical and 
anaesthesia care and training8.  
 
Healthcare technologies and technology for health are broad terms that include 
examples ranging from automobile seatbelts to vaccinations. In this review, we will 
focus on technologies and medical devices aimed at improving surgical care and 
training in LMICs. We will describe the key considerations in the development of new 
technologies along with strategies for evaluation and wider dissemination, and 
illustrate this with notable examples of where the dissemination of a new surgical 
technology has been successful and achieved impact.  
 
 




 
Innovation of novel technology spans the identification of unmet clinical needs, 
innovation design and manufacture, through to early stage evaluation. Within the low 
resource setting, two important concepts underlie this process: frugal innovation and 
responsible innovation. Frugal innovation refers to the concept of doing better with 
less. By concentrating on userBcentred design, core functionalities and reducing cost 
and waste, frugal innovation can produce elegant, contextBspecific solutions7,9. An 
example of this is MittiCool, a lowBcost, environmentally friendly refrigerator made 
from locally available materials including clay, which requires no electricity and 
elegantly addresses the unmet public health need of keeping precious food fresh in 
lowBresource environments10. To compliment fugal innovation, responsible 
innovation focuses on working sustainably and ethically, embedding innovation and 
research within the society, environment and context locally11,12. Responsible 
innovation in medical device sectors has helped foster effective partnerships 
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between industry, clinicians, researchers and policy makers and this may be 
especially important for improving innovation in LMIC contexts13–16.  
 
Frugal innovation often results in disruptive technologies, technologies which 
fundamentally alter existing systems providing a much higher value often delivered 
via frugal thinking17,18. Reverse innovation refers to the flow of innovations from low 
to highBincome countries and several technologies have impacted healthcare 
systems across the world in this way19,20. One striking example of this process is the 
use of mosquito netting in place of commercially produced mesh for abdominal wall 
hernia repair21. Key to the success of this innovation was drastic reduction in costs 
and rigorous nonBinferiority safety and efficacy evaluation, resulting in the technology 
having a powerful disruptive potential21,22. The term reverse innovation implies 
unilateral flow of ideas from LMICs to HICs and perhaps a more helpful notion is that 
of sharing innovation globally and adopting best practice wherever it originates7.  
 
Central to the tenants of both frugal and responsible innovation is the need for userB
centred design, which might involve patients and public, local surgeons, allied 
healthcare professionals, industry, academic institutes, governments and ministries 
of health23,24. Ensuring all key stakeholders provide critical feedback throughout the 
evolution of a technology is essential for its ultimate acceptance and wider adoption. 
International and local partnerships with academia and industry are key to 
technology development in global surgery. Whilst large multinational companies 
have been reluctant to target LMICs in the past, this might change in the future, 
driven by the potential market size. In the United Kingdom (UK), academic 
involvement in technological development in LMICs has been recently fuelled by 
large funding programmes from national organisations such as the National Institute 
for Health Research (NIHR) and Research Councils UK (RCUK)25,26.  
 
 
 

 
 
The evaluation of surgical and perioperative care interventions is methodologically 
challenging even in HICs, involving many interBrelated variables including the 
surgical setting and quality of care27. The IDEAL Framework (Idea, Development, 
Exploration, Assessment, LongBterm FollowBup) was conceived to facilitate the 
translation of new technologies into clinical practice through a structured framework 
that lends itself to scientific evaluation27–30. This includes the rigorous collection of 
safety and efficacy data to inform the technology’s wider adoption. Obtaining such 
data in LMIC settings is no less important, but much more challenging given financial 
and resource restraints. Within the LMIC setting, additional considerations include: 
 
1. InterBplay between HIC and LMIC partners including researchers, healthcare 
professionals and policyBmakers, to ensure responsible innovation, design 
and implementation. 
2. Patient and user acceptability assessment and outcome measurement, to 
ensure local contexts, environmental and cultural factors are considered. 
3. Rigorous process evaluations of research and technology implementation to 
ensure quality assessment and sustainable, wider adoption.  
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Conducting evaluation studies of new technologies in lowBresource settings poses 
unique challenges. A priority setting study undertaken by RosalaBHallas 	
 
identified appropriate outcome measures and training of research staff as the most 
important issues when considering clinical evaluations within LMICs31. Outcome 
measures should be chosen in collaboration with LMIC partners and include the 
feasibility of collecting longer term data when required. Incorporating existing 
technologies, such as mobile phones or wearable technologies, may assist in the 
collection of accurate data32,33. Researcher training is critical to conducting high 
quality research and in building research capacity and capability within LMICs. The 
Special Programme for Research and Training in Tropical Diseases (TDR) and the 
Global Health Network have developed the Global Competency Framework for 
Clinical Research which describes the core competencies for a research team in 
LMICs34. It provides a range of eBlearning materials to help researchers achieve 
these competencies35. Other considerations when undertaking clinical evaluations in 
LMICs include technology usability and specific training needs, research 
methodology training, local medical device and manufacture regulations, distribution 
infrastructure, and maintenance and sustainability.  
 
 
!	
	

"	

 
 
Howitt 	
 identified 3 key barriers to technology dissemination in global health7:  
 
Barrier 1 – The necessary technologies do not exist  
Barrier 2 – Technology exists, but is not accessible  
Barrier 3 – Technology is accessible, but is not adopted 
 
Some elements are limited by the pace of scientific discovery, which could be 
expedited by increased research and development funding. If the technology exists 
but is not accessible, this could be due to high costs, lack of human resources and 
infrastructure. Accessibility challenges should be considered at every stage of 
technology development, evaluation and implementation. Finally, a lack of wider 
adoption could be due to lack of key stakeholder buyBin, such as early involvement of 
patients and policyBmakers, or due to a lack of wider system and process 
considerations.  
 
Malkin 	
, along with researchers from Engineering World Health (EWH), 
highlighted three principle, designBrelated barriers to health care technology 
dissemination: cost, spare parts, and consumables36,37. ContextBspecific design for 
lowBresource settings should attempt to minimise the reliance on consumables and 
the need for maintenance and repair. Collaboration with inBcountry distributers and 
industry is important to ensure successful dissemination38. Importantly, the lack of 
technically trained staff is a significant barrier to technology development and 
adoption. This is often attributed to a ‘brain drain’ where technical skills developed to 
disseminate a technology are lost as people move out of the areas of need to more 
attractive environments36,39. One strategy to overcome this challenge is to develop 
biBlateral, international training partnerships, which has been highly effective in 
building biomedical engineering capacity40.  
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Several tools have been developed to facilitate medical technology development and 
dissemination in LMICs. The WHO Medical Device Technical Series provides 
researchers and technologists with guidelines for each stage of development and 
evaluation, including device regulations, needs assessment, human resources, 
procurement and maintenance. The WHO Health Technology Assessment (HTA) of 
Medical Devices guidelines provide practical advice around adaptive global 
healthcare considerations 41,42. Within the LMIC setting, a priority HTA strategy is the 
use of  health economics evaluation using costBeffectiveness and quality of life years 
(QALYs) to inform wider adoption and healthcare budgets 43,44.  
 
Important steps to improving technology dissemination in global surgery will be the 
effective utilisation of lowBresource specific surgical technology innovation, design, 
development and evaluation guidelines. Existing literature is often not suited to 
practical use in lowBresource environments or is prohibitively and unnecessarily 
complex. Future efforts will do well to offer versatile, context specific and applied 
practical guidance for different actors to contribute to the dissemination of novel 
surgical technologies in LMICs. Shelton offers twenty criteria to consider when 
disseminating interventions and technologies including employing userBcentred 
design, scalability and sustainability, and these should be reflected in future 
studies45. Keown 	
 offer lessons on disseminating innovation in healthcare from 
eight countries, highlighting the need to foster an organisational culture of innovation 
and adoption in health systems46.  Moreover, Howitt 	
 offer recommendations to 
different organisations such as ministries of health, industry, academic institutes and 
healthcare organisations and such guidelines should aim to facilitate interB
organisation collaboration7.  
 
Ethical practices are essential in healthcare and these should be employed 
throughout the processes of technology dissemination in global surgery47,48. 
Development and evaluation of technologies in global surgery should be held to the 
same ethical and legal standards globally. Of particular importance is the subject of 
medical device and technology donation from HICs to LMICs. This process is often 
counterBproductive and ignores many of the principles of design, development and 
evaluation discussed in this review. Donation of HIC technology with little situational 
awareness can have a negative impact on innovation and dissemination in global 
surgical technologies49. It is estimated that around 40% of donated medical 
equipment in LMICs is out of service50. However, a subsequent survey has found 
that the majority of broken instruments could be repaired costBeffectively, without the 
need to import spare parts, by investing in human resource capability51. The WHO 
and Tropical Health and Education Trust (THET) provide guidance on responsible 
and ethical practices in equipment donations to LMICs52,53.  
 
There is also a critical role for strong advocacy programmes to demonstrate the 
value that lowBcost technologies, influence industry, and lobby global organisations. 
Organisations such as the G4 Alliance for Surgical, Obstetric, Trauma, and 
Anaesthesia Care, and the International Federation of Surgical Colleges (IFSC), play 
a valuable role in showcasing successes to government organisations and policyB
makers, disseminating information to wider audiences, and ensuring that technology 
research and innovation in global surgery remains high on the international 
healthcare agenda54,55.  
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 #
 
 



 
Laparoscopic surgery is the preferred technique for many general surgical and 
gynaecological conditions due to improved shortBterm clinical outcomes56,57. These 
benefits are even more pronounced in LMICs where access to followBup care is 
limited and there is a greater urgency to return to work to prevent spiralling poverty58. 
Laparoscopy also provides a costBeffective diagnostic tool where radiological 
facilities are limited and may reduce high negative laparotomy rates 59,60. 
Laparoscopic surgery requires advanced equipment and infrastructure, including 
laparoscopes, laparoscopic instruments, and piped carbon dioxide (CO2), and 
trained surgical providers. It is usually performed under general anaesthesia, 
requiring the presence of a trained anaesthetist with appropriate equipment and 
drugs.  
 
Although these are formidable challenges, laparoscopic surgery has been 
successfully implemented in lowBresource settings with similar complication rates to 
HICs61. In a recent systematic review, Chao 	
 described several adaptive 
strategies to enhance the adoption of laparoscopic surgery in LMICs58. These 
included infrastructure and system innovations, such as soft drink companies 
providing CO2, sunlight as a light source, and lowBcost box trainers for surgical 
training62–64. Price 	
 successfully introduced laparoscopic surgery in Mongolia by 
building highBvolume, bilateral training teams and adapting to local community needs 
to build sustainable laparoscopic services63. The availability of lowBcost, high quality 
equipment, with minimal maintenance requirements, is key to successful 
implementation. An example is the Xenoscope, a laparoscope that provides high 
resolution images at an affordable cost65(see Figure 1). To avoid the need for CO2 
insufflation, abdominal wall lift devices have been developed to facilitate GILLS (Gas 
Insufflation Less Laparoscopic Surgeries). Using this technique, a range of 
laparoscopic abdominal and gynaecological procedures can be safely performed 
under spinal anaesthesia, which is readily available through trained healthcare 
workers even in the most remote environments66(see Figure 2). GILLS also negates 
the need for specialist laparoscopic instruments and trocars, where modified open 
instruments can be used to perform single incision surgery for patients in rural 
settings66,67. 
 

	
	

The management of open fractures, along with  laparotomy and caesarean section, 
are the three ‘Bellwether Procedures’, the most essential surgical procedures that all 
hospitals should be able to perform68. In LMICs, the treatment of long bone fractures 
is frequently limited to skin traction and casting, which ultimately leads to poor 
functional outcomes and protracted hospital stays69,70. The management of severe 
and open fractures is often limited to amputation71.  
 
Operative fixation of long bone fractures can reduce hospital stay, provide a quicker 
return to work, and improve fracture healing 72,73. External fixation devices, such as 
the Ilizarov frame, are favoured in lowBresource settings because of their ease of 
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application and low complication rates as compared to internal fixation methods74,75. 
Padhi and Pulate 	
 demonstrated the safe and costBeffective application of 
Ilizarov frame technology in LMICs including India, highlighting the importance of 
locally sourcing materials, local industry engagement, and reducing waste by reB
sterilisation and reBuse where safe and feasible 74,75. A further example of technology 
innovation for fracture fixation in LMICs is the ‘Joshi external stabilization system’ 
(JESS), again from India76,77(see Figure 3). This external fixation device was 
designed to be locally manufactured, versatile and reBusable, with many orthopaedic 
applications spanning age ranges, anatomical areas and mechanisms of injury78,79.  
 
 


	
 
 
The safe delivery of anaesthetic and perioperative care is of paramount importance 
to improving surgical outcomes. The WHO Safe Surgery Saves Lives programme 
introduced the WHO Surgical Safety Checklist which has had an impact on surgical 
safety across the world80–82. One of the mandated items on the checklist is the use of 
pulse oximetry, which is the only piece of equipment required. Funk 	
 highlighted 
the global lack of pulse oximetry as a significant unmet global health need83. This 
need was met by the NGO LifeBox, an international charitable organisation who 
developed a novel pulse oximeter designed specifically for the needs of lowBresource 
settings84,85(see Figure 4). The LifeBox pulse oximeter project has disseminated over 
15,000 pulse oximeters to hospitals across 100 countries86. Its success is attributed 
to careful consideration of the design specification, focusing on minimal standards 
and core functionalities, and building in affordable cost, durability, and lowBresource 
environmental factors, such as limited power supply and distribution challenges87. 
Other key disseminating strategies included LMIC userBcentred design, effective 
industry and local partner engagement, and importantly, rigorous clinical 
evaluation88–90. 
 


 
 
The WHO acknowledges that significant investment in healthcare professional 
education is required to realise UHC by 2030. It estimates that globally there is a 
shortage of over 7.2 million healthcare providers91,92. This shortage is particularly 
acute in LMICs where the lowest workforce densities are found 8,92. The principles of 
‘task shifting’ or ‘task sharing’ have been developed as an innovative model of 
healthcare delivery, addressing the human resource gap by training alternative 
surgical providers93. Training surgeons is expensive, timeBconsuming and often 
relies on skill acquisition along a learning curve that involves a high volume of cases 
with expert supervision94. Advances in simulation and immersive technologies may 
address these challenges by providing a safe and scalable training environment94. A 
study from Rwanda confirmed the feasibility of simulation based training to improve 
operative skills when delivered as a brief training intervention in LMICs95. LMICs 
have the same drivers as HICs to the adoption of simulation and immersive 
technologies as part of surgical training. These technologies may be particularly 
suited to LMICs due to the high traineeBtrainer ratios, limited number of operating 
rooms, and reliance on shortBterm training from visiting international trainers. 
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Virtual reality has been explored in the teaching of surgeons across the world using 
live streaming and immersive training modules96. Augmented reality has also been 
explored, allowing surgical trainers to ‘scrubBin’ with an operating LMIC team to 
teach and deliver surgical care97. These technologies have been evaluated in a 
variety of global surgical training scenarios98–101. The wider use of these training 
technologies will be determined by infrastructure challenges, such as power supply 
and internet access, as well as a better understanding of how they might be 
incorporated into traditional training methods.  
 




The dissemination of technologies in global surgery faces several challenges unique 
to working in lowBresource environments. Employing the principles of frugal and 
responsible innovation and aligning evaluation and development to high scientific 
standards will help in overcoming some of these challenges. Generating centralised, 
international technology repositories such as the WHO Compendium of innovative 
health technologies for lowBresource settings will facilitate the sharing of best 
practice102. In the future, technologies developed for lowBresource settings using 
frugal design will be used to improve health and stem the rising costs of healthcare 
worldBwide. 
 
Capacity and need assessment are important, but international efforts should now 
take a step beyond this and begin catalysing technology dissemination to improve 
outcomes for surgical patients in LMICs. Principal core strategies to achieve this are 
leveraging international funding, interdisciplinary collaboration involving all key 
stakeholders including industry, academics, clinicians and policyBmakers, and 
scientific frugal design, development and evaluation. Technology alone is not 
enough, process and system innovations and evaluations considering the wider 
context are required to implement and disseminate surgical technology effectively. 
Practical and contextBspecific guidance for actors in global surgical technologies will 
catalyse this process to improve outcomes for patients in LMICs.  
 
$	
% 
 
Key driving factors of technology innovation and dissemination in global surgery 
include (see Figure 5): 
 
1. Understanding local contexts, systems and environments ensuring 
complimentary process and system innovations accompany technology. 
2. Rigorous, appropriate and timely evaluation and evidence synthesis to 
inform embedded, sustainable adoption and implementation.  
3. Effective interdisciplinary collaboration with local and international 
industry, policyBmakers, healthcare professionals and patients, and 
academic institutes. 
4. Employing ethical principles, responsible innovation and frugal design at 
every stage, respecting cultures and contexts across different countries.  
5. Investing in local human resources to build research, technology and 
equipment capacity and capability locally to enhance global workforces.   
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